Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Angi Inc
ANGI
$195M
| $6.59M | ﹤0.01% |
54,238
-6,890
| -11% | -$628K |
|
|
CTT
2177
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $6.59M | ﹤0.01% |
744,265
+8,186
| +1% | +$63.4K |
|
|
TGI
2178
DELISTED
Triumph Group
TGI
| $6.58M | ﹤0.01% |
730,174
+36,207
| +5% | +$268K |
|
2179
Impinj
PI
$5.01B
| $6.57M | ﹤0.01% |
239,199
+4,685
| +2% | +$110K |
|
2180
Andersons Inc
ANDE
$2.41B
| $6.56M | ﹤0.01% |
477,087
-2,979
| -0.6% | -$43.3K |
|
2181
Central Pacific Financial
CPF
$1.03B
| $6.55M | ﹤0.01% |
408,766
+13,021
| +3% | +$207K |
|
2182
i3 Verticals
IIIV
$431M
| $6.54M | ﹤0.01% |
216,197
+2,677
| +1% | +$68K |
|
2183
FB Financial Corp
FBK
$3.1B
| $6.52M | ﹤0.01% |
263,231
+12,537
| +5% | +$279K |
|
|
GTS
2184
DELISTED
Triple-S Management Corporation
GTS
| $6.51M | ﹤0.01% |
342,388
+10,162
| +3% | +$174K |
|
2185
Protagonist Therapeutics
PTGX
$8.8B
| $6.5M | ﹤0.01% |
368,370
+74,774
| +25% | +$938K |
|
2186
Groupon
GRPN
$1.06B
| $6.5M | ﹤0.01% |
358,700
+18,635
| +5% | +$415K |
|
|
VSLR
2187
DELISTED
VIVINT SOLAR, INC.
VSLR
| $6.5M | ﹤0.01% |
656,309
+41,131
| +7% | +$296K |
|
2188
Dime Commercial Bancshares
DCOM
$1.82B
| $6.48M | ﹤0.01% |
283,783
+9,907
| +4% | +$203K |
|
|
AGNT
2189
AGNT Inc
AGNT
$674M
| $6.46M | ﹤0.01% |
758,298
+56,136
| +8% | +$288K |
|
2190
Live Oak Bancshares
LOB
$2.02B
| $6.45M | ﹤0.01% |
444,414
+41,751
| +10% | +$566K |
|
|
BWIN
2191
Baldwin Insurance Group
BWIN
$2.8B
| $6.45M | ﹤0.01% |
373,330
+106,512
| +40% | +$1.29M |
|
2192
Buckle
BKE
$2.35B
| $6.43M | ﹤0.01% |
410,107
+7,585
| +2% | +$114K |
|
|
ATRS
2193
DELISTED
Antares Pharma, Inc.
ATRS
| $6.43M | ﹤0.01% |
2,338,263
+43,737
| +2% | +$122K |
|
2194
Waterstone Financial
WSBF
$378M
| $6.43M | ﹤0.01% |
433,431
+913
| +0.2% | +$12.9K |
|
|
KREF
2195
KKR Real Estate Finance Trust
KREF
$466M
| $6.41M | ﹤0.01% |
386,495
+33,185
| +9% | +$525K |
|
|
DBD
2196
DELISTED
Diebold Nixdorf Incorporated
DBD
| $6.4M | ﹤0.01% |
1,056,201
-7,322
| -0.7% | -$36.1K |
|
|
XENT
2197
DELISTED
Intersect ENT, Inc
XENT
| $6.4M | ﹤0.01% |
472,619
+23,273
| +5% | +$271K |
|
2198
Bank of Marin Bancorp
BMRC
$469M
| $6.39M | ﹤0.01% |
191,881
+2,913
| +2% | +$92.2K |
|
|
CODX
2199
Co-Diagnostics
CODX
$5.56M
| $6.39M | ﹤0.01% |
11,015
+6,972
| +172% | +$3.18M |
|
2200
Pitney Bowes
PBI
$2.57B
| $6.39M | ﹤0.01% |
2,457,887
+55,354
| +2% | +$138K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.